Patel A R, Dubrey S W, Mendes L A, Skinner M, Cupples A, Falk R H, Davidoff R
Evans Memorial Department of Clinical Research, Arthritis Research Center, Boston University Medical Center, Massachusetts 02118, USA.
Am J Cardiol. 1997 Aug 15;80(4):486-92. doi: 10.1016/s0002-9149(97)00400-1.
This study was designed to characterize the geometry and function of the right ventricle and its prognostic significance in patients with primary (AL) cardiac amyloidosis. AL amyloidosis is an infiltrative systemic disease that can result in thickening of heart structures and rapidly progressive congestive heart failure due to restrictive ventricular physiology and eventual systolic dysfunction. Thirty-seven patients with AL amyloid heart involvement and 20 normal control subjects were evaluated using 2-dimensional and Doppler echocardiography. Based on the ratio of left-to-right end-diastolic ventricular chamber areas, patients were classified into 2 groups: 25 patients with disproportionate right ventricular (RV) dilation (left ventricular to RV ratio < or = 2) and 12 with a ventricular area ratio > 2. Patients with a relatively dilated right ventricle (ratio < or = 2) had a shorter median survival (4 months) compared with patients with an area ratio > 2 (10 months, p <0.003). Of multiple clinical, echocardiographic, and Doppler features entered into a multifactorial model, a ventricular area ratio < or = 2 remained the only independent predictor of survival. Patients with AL amyloid heart disease represent a heterogeneous population with regard to both prognosis and the relative degree of right to left ventricular dilation. RV dilation in patients with amyloid heart disease appears to be associated with more severe involvement and is associated with a very poor prognosis with a median survival of only 4 months.
本研究旨在描述原发性(AL)心脏淀粉样变性患者右心室的几何形态、功能及其预后意义。AL淀粉样变性是一种浸润性全身性疾病,可导致心脏结构增厚,并因限制性心室生理功能及最终的收缩功能障碍而迅速进展为充血性心力衰竭。对37例有AL淀粉样变性心脏受累的患者和20名正常对照者进行了二维和多普勒超声心动图评估。根据舒张末期左、右心室腔面积之比,将患者分为两组:25例右心室(RV)不成比例扩张患者(左心室与RV之比≤2)和12例心室面积比>2的患者。右心室相对扩张(比值≤2)的患者中位生存期较短(4个月),而面积比>2的患者为10个月(p<0.003)。在纳入多因素模型的多项临床、超声心动图和多普勒特征中,心室面积比≤2仍然是生存的唯一独立预测因素。就预后和右心室与左心室扩张的相对程度而言,AL淀粉样变性心脏病患者是一个异质性群体。淀粉样变性心脏病患者的RV扩张似乎与更严重的受累相关,并且与非常差的预后相关,中位生存期仅为4个月。